MedPath

Microvascular Recovery in Acute MI, a multi center, prospective, randomized, single blind parallel-group comparison of sonothrombolysis versus standard of care performed after (post) coronary reperfusion (primary PCI).

Phase 3
Completed
Conditions
myocardial infarction and microcirculation
10011082
Registration Number
NL-OMON52724
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
66
Inclusion Criteria

Patients presenting with STEMI within 12 hours of symptom onset and persisting
ST-elevation on the ECG after PCI >=30% in the lead with the highest elevation
compared to baseline ECG
Age >=30 years.
Adequate images with echocardiography

Exclusion Criteria

1. Previous coronary bypass surgery
2. Cardiogenic shock
3. Known or suspected hypersensitivity to ultrasound contrast agent used for
the study
4. Known bleeding diathesis or contraindication to glycoprotein 2b/3a
inhibitors, anticoagulants, or aspirin
6. Known large right to left intracardiac shunts

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Som of ST-segment elevation after 60 min post initiation of Study Protocol </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Partial (>50%) and complete (>=70%) ST-segment resolution.<br /><br>- Size of the infarct as measured by late gadolinium enhancement (LGE) on<br /><br>cardiac magnetic resonance imaging (CMR) assessed on day 3-7 days and 4-6<br /><br>months after infarction (on patients who can have a CMR)<br /><br>- Left ventricular remodelling as assessed by contrast enhanced<br /><br>echocardiography.<br /><br>- The composite of all-cause death, cardiogenic shock, need for<br /><br>defibrillator placement, or congestive heart failure (CHF) through day 180</p><br>
© Copyright 2025. All Rights Reserved by MedPath